BioSpace News Archive

Wilmington, Delaware, United States, Transparency Market Research Inc. – Experiments in the field of biology includes the use of drugs or gene editing or implants which improve the capabilities or qualities of living organisms.

Basilea Pharmaceutica Ltd, a commercial-stage biopharmaceutical company, announced its results for the first half-year ended June 30, 2022.

Amsterdam, the Netherlands - Royal Philips, a global leader in health technology, announced that Roy Jakobs is proposed to succeed Frans van Houten as President and Chief Executive Officer, effective October 15, 2022.

So-Young International Inc., the largest and most vibrant social community in China for consumers, professionals and service providers in the medical aesthetics industry, announced its unaudited financial results for the second quarter ended June 30, 2022.

MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market and the JASDAQ Market of the Tokyo Stock Exchange, announced that it plans to participate in RECLAIM, a grant-funded, multi-center, randomized, clinical trial to evaluate MN-166 and other therapies for the treatment of Long COVID, the lingering symptoms of COVID-19.

Immunic, Inc. announced that the company has received a Notice of Allowance from the U.S. Patent and Trademark Office for patent application 16/646130, entitled, “Compound Having Cyclic Structure.” The patent covers composition-of-matter of IMU-856 and related pharmaceutical compositions and is expected to provide protection into at least 2038, without accounting for potential Patent Term Extension.

Wilmington, Delaware, United States, Transparency Market Research Inc. – Epilepsy is a chronic neurological disorder that can cause unfounded and ongoing seizures.

Wilmington, Delaware, United States, Transparency Market Research Inc. – Fractional flow reserve is a technique used in coronary catheterization to measure pressure differences across a coronary artery stenosis to determine the possibility of the stenosis impeding delivery of oxygen to the heart muscle.

OKYO Pharma Limited is pleased to announce its final audited results for the year ended 31 March 2022.

Mainz Biomed N.V., a molecular genetics diagnostic company specializing in the early detection of cancer, and Dante Genomics, a global leader in genomics and precision medicine, announced the formal commencement of ColoAlert’s consumer commercial program in Italy and the United Arab Emirates.